Alla Keyzner, MD
- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
- Cancer (Oncology)
- Hospital Affiliation
- The Mount Sinai Hospital
- Ruttenberg Treatment Center 212-241-6021 212-241-6021
Alla Keyzner, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. She is Associate Director of the Allogeneic Stem Cell Transplant Program and Co-chair of the Myeloid Diagnostic Management Team. Dr. Keyzner also serves as Quality Director for the Bone Marrow Transplant Program.
Dr. Keyzner’s clinical and research focus is on the use and optimization of allogeneic stem cell transplant for the management of patients with myeloid malignancies. She is the site principal investigator for numerous multi-center clinical trials studying new therapeutic approaches for acute myeloid leukemia and cord blood transplantation. Dr. Keyzner serves on multiple committees of the Center for International Blood and Marrow Transplant Research related to chronic leukemia, acute leukemia, and graft sources and manipulation, and is a member of the Cord Blood Transplantation special interest group of the American Society for Transplantation and Cellular Therapy.
- AL Amyloidosis
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Allogeneic
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Hodgkin's Disease
- Hodgkin's Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
MD, Drexel University College of Medicine
Residency, Internal Medicine
Westmed Medical Group
Westmed Medical Group
Fellowship, Bone Marrow Trans.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Keyzner did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.